A Randomized, Crossover, Drug-Drug Interaction Study Investigating the Effect of Clopidogrel on Dasabuvir in Healthy Volunteers

Trial Profile

A Randomized, Crossover, Drug-Drug Interaction Study Investigating the Effect of Clopidogrel on Dasabuvir in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2018

At a glance

  • Drugs Dasabuvir (Primary) ; Clopidogrel; Ritonavir
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Apr 2018 Results published in the Clinical Pharmacology and Therapeutics
    • 27 Mar 2018 New trial record
    • 24 Mar 2018 According to results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, the pharmacokinetic data was available for analysis on 25 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top